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 ABSTRACT  
 
Background  
Endothelial cell damage and glycocalyx shedding following trauma can increase the risk of 
inflammation, coagulopathy, vascular permeability and death. Bedside sublingual video-
microscopy may detect worse flow and perfusion associated with this endotheliopathy. We 
compared markers of endotheliopathy with physical flow dynamics following traumatic 
hemorrhagic shock (THS).  
 
Methods 
Sublingual incident dark field video-microscopy was performed at three time-points 
following injury (<10h; 10–30h; and 30–50h). Values for microcirculatory flow index (MFI), 
Point Of carE Microcirculation assessment (POEM) score, proportion of perfused vessels 
(PPV), microcirculatory heterogeneity index (MHI), perfused vessel density (PVD), and total 
vessel density (TVD) were obtained. ELISAs were performed to measure concentrations of 
thrombomodulin and syndecan-1 as biomarkers of endothelial cell damage and glycocalyx 
shedding respectively. Flow parameters were dichotomised to above and below average, and 
biomarkers compared between groups; below average MFI, POEM, PPV, PVD, and TVD, 
and above average MHI were considered poor microcirculatory flow dynamics.    
 
Results   
155 sublingual video-microscopy clips corresponding to 39 time-points from 17 trauma 
patients were analysed. Median age was 35 (IQR 25–52); 16/17 were male.  
Within 10h of injury, syndecan-1 concentrations were significantly higher compared to 17 
age and sex-matched healthy controls (30 (IQR 20–44) ng/ml) for worse TVD (78 (IQR 63–
Abstract
 417) ng/ml); PVD (156 (IQR 63–590) ng/ml); PPV (249 (IQR 64–578) ng/ml); MFI (249 
(IQR 64–578) ng/ml); MHI (45 (IQR 38–68) ng/ml); and POEM scores (108 (IQR 44–462) 
ng/ml) (all p<0.01). Thrombomodulin was also raised within 10 hours of injury when 
compared to healthy controls (2.9 (IQR 2.2–3.4) ng/ml) for worse PPV (4.1 (IQR 3.4–6.2) 
ng/ml) and MFI (4.1 (IQR 3.4–6.2) ng/ml) (both p<0.05).  
 
Conclusions    
Endothelial cell damage and glycocalyx shedding are associated with worse flow, density, 
and heterogeneity within micro-vessels following THS. The clinical utility of these 
biomarkers and flow parameters at the bedside are yet to be elucidated.    
 
Study type / level of evidence  
Prognostic study, Level III  
 
Key words 
Endothelium, glycocalyx, trauma, hemorrhage, microcirculation 
 
 Poor microcirculatory flow dynamics are associated with endothelial cell 
damage and glycocalyx shedding following traumatic hemorrhagic shock  
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BACKGROUND 
  
There has been considerable interest in the endotheliopathy of trauma, since it is associated 
with increased vascular permeability1, is an independent predictor of mortality2, and may be a 
key determinant in the development of inflammation and coagulopathy3. In particular, 
endothelial glycocalyx shedding may have a role in microcirculatory dysfunction due to its 
essential role in the integrity and function of the oxygen exchange surface of all micro-
vessels4, 5. Endotheliopathy of trauma is associated with sympathoadrenal activation6, 7, and 
may be induced by the action of damage-associated molecular patterns (DAMPs) that are 
released into the circulation following tissue injury8, 9, as well as raised levels of pro-
inflammatory cytokines responsible for disruption of endothelial integrity10. Aside from the 
inflammatory and coagulopathic consequences of endotheliopathy, there may also be 
derangements in flow dynamics within the micro-vessels so that oxygen perfusion is 
inadequate, leading to hypoxia and acidosis. Prior to the current study, the relationship 
between endotheliopathy and microcirculatory flow dynamics following traumatic 
hemorrhagic shock (THS) has not been investigated.   
 
Away from the patient, enzyme-linked immunosorbent assays (ELISA) can be performed for 
surrogate markers of endotheliopathy, such as thrombomodulin (CD141) and syndecan-1 
(CD138). Thrombomodulin is a transmembrane glycoprotein in endothelial cells that acts as a 
cofactor during activation of Protein C by thrombin6, 11. It is not secreted by endothelial cells, 
but is present in the circulation due to endothelial cell damage12. This makes it a useful 
biomarker of endothelial injury, and has been used in this role for patients following sepsis6, 
13, myocardial infarction14, cardiac arrest15, and trauma2, 7, 16. Syndecan-1 is a transmembrane 
heparan sulfate glycoprotein whose extracellular domain forms part of the endothelial 
Manuscript
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glycocalyx. It has been used as a biomarker for glycocalyx shedding for patients following 
trauma2, 10, 17.  
 
At the bedside, non-invasive video-microscopy can be used to visualise the flow of red blood 
cells in the sublingual microcirculation. The latest incident dark field technology allows for 
the acquisition of high definition views of the flow and perfusion of these micro-vessels 
whose primary function is oxygen and substrate exchange. This technique has been used to 
examine the response of the microcirculation to critical illness, sepsis and shock18. More 
recently, investigators have demonstrated a prognostic value in this technology for 
hemorrhagic trauma19, in particular in the detection of loss of hemodynamic coherence20. 
There have been no clinical studies that have tested whether glycocalyx shedding and 
endothelial cell damage are associated with poorer flow dynamics in the microcirculation.  
 
The aim of the current study was to test whether endotheliopathy following traumatic 
hemorrhagic shock was associated with physical changes in the flow, density and perfusion 
of vessels in the microcirculation, from initial resuscitation to stabilization in the Intensive 
Care Unit (ICU). We hypothesized that there would be an association between 
endotheliopathy and poor flow dynamics of the microcirculation.  
 
 
 
 
 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
3 
 
METHODS 
 
Study design 
A prospective longitudinal observational study was conducted in order to compare flow 
dynamic parameters of the microcirculation with serum markers of endothelial damage and 
glycocalyx shedding. All data are from a single site in the MICROSHOCK study21.  This 
study had been granted prior ethical approval (Research Ethics Committee reference: 
14/YH/0078; Yorkshire and the Humber Leeds West), and a protocol was published in 
advance21.  
 
Patient selection 
Patients who were potentially eligible for inclusion at a single Major Trauma Center 
(University Hospitals Birmingham, UK) were identified through the screening of trauma 
activations. Trauma patients were eligible for inclusion if they required blood products, had 
been intubated, required admission to ICU, and had a point-of-care lactate of greater than 
2mmol/l. They were enrolled into the study either in the Emergency Department (ED) or ICU 
depending on suitability for study observations. Selection bias was minimized by ensuring 
that there were no significant differences between patients enrolled in the study and those that 
were eligible but not included.  
 
Data collection 
Patient demographics (age, gender), injury details (including mechanism and timings), 
physiological parameters (heart rate and systolic blood pressure), and Glasgow Coma Scale 
(GCS) were recorded prospectively, and then corroborated using a combination of 
electronical and paper medical records. The most recent point of care lactate reading to each 
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time-point was also recorded, as well as the number and type of blood products used during 
the study period. Injury Severity Scores (ISS) were obtained from the Trauma Audit and 
Research Network, a central validated resource in the UK. Outcomes recorded for patients 
included ICU-free and hospital-free days (calculated by recording the number of days that the 
patient was present in ICU and hospital respectively during a period of 30 days), mortality 
within 30 days, and Sequential Organ Failure Assessment (SOFA) scores at days 3, 6, and 10.  
 
Sublingual video-microscopy 
A single operator (D.N.N.) conducted incident dark field (IDF) video-microscopy in order to 
acquire non-invasive video clips of the sublingual microcirculation (Cytocam, Braedius 
Medical B.V., Huizen, The Netherlands). Briefly, the camera was placed gently under the 
tongue until a clear view of the mucosal microcirculation was acquired, without blood or 
saliva artefact, with minimal pressure, and optimal focus and illumination according to 
consensus quality requirements for this technology22. Multiple clips of 100 frames each were 
recorded and stored on a computer for analysis. At least 5 good quality clips were recorded at 
each time-point in order to facilitate optimal analysis23.  
 
Microcirculatory analysis 
Videos that had been acquired by IDF video-microscopy were exported for analysis and were 
individually graded for quality according to the most commonly reported domains 
(illumination, focus, content, duration, pressure, and stability)24. Of the highest quality clips, 
3-5 from each patient time-point were kept for analysis. These clips were allocated random 
numbers to ensure that their analysis was blinded to patient, time-point, and clinical status. 
Semi-automated analysis was undertaken for each clip using dedicated computer software 
(Automated Vascular Analysis V.3.2, Microvision Medical, The Netherlands). All videos 
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were then un-blinded, and the time-points assigned average values for total vessel density 
(TVD, mm/mm2), perfused vessel density (PVD, mm/mm2), proportion of perfused vessels 
(PPV, %), microcirculatory flow index (MFI), and microcirculatory heterogeneity index 
(MHI) according to consensus guidelines for reporting sublingual microcirculation23. In 
addition, point of care microcirculation (POEM) scores (a composite score for flow and 
heterogeneity)25 were allocated for each time-point. The methodology for the allocation of 
POEM scores is described in detail elsewhere25. In summary, flow is defined as “normal”, 
“impaired”, or “critical” for a video clip if <25%, 25–50%, or >50% of the vessels in the 
visual field respectively are sluggish or stopped. In addition, heterogeneity is either “present” 
or “absent” if >5 or <5 vessel segments have different flow to the remainder. This is repeated 
4 times, and an algorithm calculates the overall score based on the majority of responses. A 
score is allocated from 1 (worst) to 5 (best).   
 
Serum sampling 
At the same time-point at which video-microscopy was performed, a 6 ml sample of 
peripheral blood was taken from an available venous access point. After a 30-minute 
incubation at room temperature, samples were spun at 1,620 x g for 10 minutes at 4oC, after 
which aliquots of serum were stored in cryotubes at -80oC. Serum samples were collected and 
stored in the same manner for 17 healthy volunteers, matched for age and sex to the patient 
cohort. 
 
Enzyme-linked immunosorbent assays 
Commercially available ELISAs were used according to their relevant protocols for the 
measurement of serum concentrations of syndecan-1 (CD 138; Abcam; product code 
ab46506, Cambridge, MA) as a surrogate marker of endothelial glycocalyx shedding, and 
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thrombomodulin (CD 141; Abcam; product code ab46508, Cambridge, MA) as a surrogate 
marker of endothelial cell damage.  
 
Data analysis 
Continuous data were tested for normality using the Shapiro-Wilk test. Normal data are 
presented as mean and standard deviation (SD), and non-normal data are presented as median 
and interquartile range (IQR). Spearman's rank correlation coefficient was used to determine 
the correlation between thrombomodulin and syndecan-1 concentrations for all patients, as 
well as the correlation between each of the biomarker concentrations and flow dynamics with 
lactate. Patient time-points were calculated from time of injury, and were divided into three 
groups: (i) <10 hours; (ii) 10 – 30 hours; and (iii) 30 – 50 hours since injury.  
It is well established in previous studies of microcirculatory flow dynamics that 
healthy volunteers score near-maximum values of the traditional parameters of choice (such 
as PPV close to 100%, MFI equal to or close to 3.0, and heterogeneity near to 0)26-28. 
Comparison of flow dynamics between healthy controls and critically unwell patients is 
therefore unlikely to yield surprising or meaningful results. Of greater interest would be the 
difference between patients within the critically unwell cohort. In order to test the association 
of flow dynamics and endothelial cell damage and glycocalyx shedding amongst the injured 
cohort in the current study, flow dynamic parameters were dichotomised above and below the 
average value at each time-point (the median for non-normal data and the mean for normal 
data) in a manner similar to that previously reported for microcirculatory parameters29. The 
“worse” group were considered to have poor microcirculatory flow dynamics. Concentrations 
of syndecan-1 and thrombomodulin were compared between these “above” and “below” 
average groups. Multiple pairwise comparisons of biomarkers between patients and healthy 
controls were made using Dunn’s multiple comparison’s tests. Comparison of flow dynamics 
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between time points was made using the Skillings-Mack test for repeated measures of non-
normal data that allows for some missing values. A p-value of <0.05 was considered 
statistically significant. Box and whisker graphs are presented according to the Tukey 
method, with horizontal bars as the median value, boxes as the interquartile range, and the 
upper and lower whiskers being 1.5 times the interquartile range above and below the 75th 
and 25th percentile respectively.  
 
 
RESULTS 
 
Patient characteristics 
Analysis was performed for 155 sublingual video-microscopy clips that corresponded to 39 
time-points from 17 trauma patients. Six patients had data from all three time points, 10 had 
data from two time points, and one patient died after the first time point. Patient 
characteristics are shown in Table 1. 
 
Endothelial cell damage and glycocalyx shedding 
When pairs of thrombomodulin and syndecan-1 concentrations for all healthy controls and 
patients were compared, there was a significant correlation between them (rho = 0.634; p < 
0.001) (Supplementary Digital Content Figure 1), indicating an association between 
glycocalyx shedding and endothelial cell damage.  
 
Endotheliopathy, flow disruption and perfusion  
Thrombomodulin and syndecan-1 were both significantly correlated with lactate 
concentrations (Figure 1) (rho = 0.331; p < 0.05; and rho = 0.440; p < 0.01 respectively), 
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indicating that endotheliopathy is associated with perfusion mismatch. When flow dynamics 
were compared to lactate concentrations, there were significant correlations with PVD (rho = 
-0.416;  p< 0.01); PPV (rho = -0.440; p < 0.01); MFI (rho = -0.464; p < 0.01); MHI (rho = 
0.363; p < 0.05); and POEM score (rho = -0.440; p < 0.01). There was no significant 
correlation with TVD (rho = -0.312; p = 0.053).  
 
Glycocalyx shedding and endothelial cell damage over time 
Figure 2 illustrates the concentrations of syndecan-1 and thrombomodulin for all patients 
over time. When syndecan-1 concentrations were compared with healthy controls (30 (IQR 
20 – 44) ng/ml), they were significantly higher at the 10h (63 (IQR 41 – 296) ng/ml), 10-30h 
(61 (IQR 38 – 109) ng/ml) and 30-50h (51 (IQR 34 – 90) ng/ml) time-points. In contrast, 
there were no significant differences between thrombomodulin concentrations for healthy 
controls (2.9 (IQR 2.2 – 3.4) ng/ml) and patients at the <10h (3.7 (IQR 2.8 – 4.7) ng/mL), 10-
30h (3.9 (IQR 3.4 – 4.5) ng/ml), or 30-50h (2.9 (IQR 2.4 – 6.0) ng/ml) time-points.    
 
Flow parameters improve over time 
Flow dynamics for all three time-points are illustrated in Figure 3. There was a significant 
improvement over time for measures of flow (MFI; p < 0.001), perfusion (PPV; p < 0.001), 
heterogeneity (MHI; p < 0.001), and combined flow and heterogeneity (POEM score; p < 
0.01). There were no significant differences over time for measures of total or perfused vessel 
density (TVD (p = 0.276) and PVD (p = 0.389) respectively).  
 
Glycocalyx shedding and flow dynamics 
Figure 4 illustrates the concentrations of syndecan-1 at each time-point relative to flow 
dynamic parameters. Higher heterogeneity of flow (MHI), as well as worse perfusion (PPV) 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 
 
and flow (MFI) were associated with glycocalyx shedding at all three time-points. The most 
significant differences were observed within 10h of injury; at this time-point, syndecan-1 
concentrations were significantly higher than healthy controls (30 (IQR 20 – 44) ng/ml) when 
there was worse TVD (78 (IQR 63 – 417) ng/ml); PVD (156 (IQR 63 – 590) ng/ml); PPV 
(249 (IQR 64 – 578) ng/ml); MFI (249 (IQR 64 – 578) ng/ml); MHI (45 (IQR 38 – 68) 
ng/ml); and POEM scores (108 (IQR 44 – 462) ng/ml) (all p<0.01). Below average TVD and 
PVD were associated with glycocalyx shedding at <10h and 10-30h (all p < 0.05), but not at 
the 30-50h time-points. 
 
Endothelial cell damage and flow dynamics  
Figure 5 illustrates the concentration of thrombomodulin at each time-point relative to flow 
dynamic parameters. In contrast with syndecan-1, thrombomodulin was only raised within 10 
hours of injury when compared to healthy controls (2.9 (IQR 2.2 – 3.4) ng/ml) for worse PPV 
(4.1 (IQR 3.4 – 6.2) ng/ml) and MFI (4.1 (IQR 3.4 – 6.2) ng/ml) (both p<0.05). Below 
average density (TVD) and functional density (PVD) were associated with endothelial 
damage only at the 10-30h time-point (3.7 (IQR 3.3 – 3.9) ng/ml and 3.7 (IQR 3.3 – 3.9) 
ng/ml respectively), but not at the <10h or 30-50h time-points. No associations were found 
between endothelial cell damage and heterogeneity of flow (MHI) or POEM scores (p values 
all non-significant). 
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DISCUSSION 
 
We present for the first time an association between endotheliopathy and impaired 
microcirculatory perfusion following traumatic hemorrhagic shock, the effects of which were 
most striking within 10 hours of injury. The correlation between serum lactate readings and 
both endothelial biomarkers and microcirculatory flow dynamics suggests a concurrent 
oxygen perfusion deficit associated with endotheliopathy and microcirculatory flow 
disruption. Deterioration in flow may represent one of the mechanisms of microcirculatory 
dysfunction attributable to endotheliopathy, and poor flow dynamics following shock may be 
responsible for worsening endotheliopathy. Although the current study does not attribute 
causality, it is likely that poor flow, glycocalyx shedding and endothelial cell disruption are 
mutually detrimental, and together contribute to derangement in oxygen exchange, 
inflammatory dysregulation and coagulopathy following trauma and hemorrhagic shock.    
 
Other investigators have reported a strong association between injury severity, 
catecholamine-driven sympathoadrenal response, hypocoagulability, and raised levels of 
syndecan-1 and thrombomodulin as markers of glycocalyx shedding and endothelial cell 
injury2, 30. Trauma-induced coagulopathy has been observed in patients with glycocalyx 
shedding, and it has been postulated that endogenous autoheparinization may be responsible 
for this31, as well as the generation of thrombin and activation of protein C32. The term 
“shock-induced endotheliopathy” (SHINE) has been used to describe the same phenotype 
observed in several different critical illnesses characterised by shock33. These observed 
effects of endotheliopathy may be considered in the context of the microcirculatory flow 
disruption observed in the current study, which are likely to exacerbate the pathologic 
process by reducing the efficient flow of red cells and oxygen delivery to tissues.   
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It is notable that most of the flow parameters showed dramatic improvement over the three 
time-points (Figure 3), and yet the glycocalyx does not appear to have been restored to 
normality according to the levels of syndecan-1 (Figure 2). Although the median levels of 
syndecan-1 improved over time, they were still raised above that of healthy controls, a 
finding in keeping with a previous study10. Restoration of flow parameters may be a 
reflection of a pressure-based resuscitation strategy and goal-directed therapy aimed at 
restoring oxygen perfusion and reducing acidosis, rather than any therapy deliberately 
targeted at repairing the endothelium. The exact consequences of incomplete endothelial 
restoration are unknown, but it seems likely that any inflammatory and coagulopathic 
processes caused by the injured endothelium would continue to have an effect on subsequent 
clinical progression until the endothelium was returned to its normal state.   
 
The flow parameters observed in this study included those used for research but also a point 
of care tool that may be used at the bedside25. Other investigators have also proposed bedside 
utilisation of more traditional research parameters34, 35. Sublingual video-microscopy is safe 
to be performed for patients following injury, even in the ED for haemodynamically unstable 
patients36. If conducted in real time, these parameters may be able to aid in the identification 
of patients likely to suffer from ongoing consequences of endotheliopathy by directly 
visualising the dynamic changes from initial resuscitation through to ICU. Since 
endotheliopathy may predict poor patient outcome2, 13, this information is of potential value 
in the clinical context.  
 
A recent experimental swine model of trauma and hemorrhagic shock showed that even with 
identical injury and hemorrhage, there was a wide variation in microcirculatory dysfunction 
between animals from the outset29, confirming the findings of an earlier small animal 
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model37. The level of microcirculatory dysfunction was not predictable based on injury-
specific details, but instead may be subject to genetic susceptibility. The same may also be 
true for injured humans; for example, age is associated with a different biomarker profile 
related to circulating inflammatory and sympathoadrenal mediators38. Diagnostic techniques 
may be desirable if they can distinguish between patients at risk of endotheliopathy and those 
who are not. In the current study there was a wide variation in biomarker levels and flow 
dynamics parameters, with some overlap in values between healthy volunteers and injured 
patients. Furthermore, although statistically significant, the correlations between the lactate 
and the study parameters of interest are not perfect. These are finding that might be 
anticipated in a trauma population due to the heterogeneity of injury patterns and severity 
with differences in genetic susceptibility between patients. Biomarkers and flow dynamics 
alone may not be sensitive or specific enough to determine clinical decisions during 
resuscitation, but may have a role in the overall assessment of patients in the context of their 
other physiological and biochemical parameters. This may be especially relevant if 
endothelial and microcirculatory behaviour is subject to genetic variation between individuals 
in the presence of the same injury patterns.     
 
The current management strategy for traumatic hemorrhagic shock involves an early damage 
control resuscitation (DCR) phase that begins during the pre-hospital evacuation of the 
casualty, followed by fluid resuscitation with empirical ratios of packed red cells, plasma, 
and platelets. Following empirical resuscitation, a more bespoke, individualized approach to 
ongoing resuscitation is favorable, using additional diagnostic modalities such as 
thromboelastography39. Currently there is no point-of-care test for endotheliopathy of trauma, 
but it appears that sublingual video-microscopy has the potential to provide information 
relating to this important pathology during individualized resuscitation. Previous 
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investigators have described a restoration of the endothelial glycocalyx with plasma-based 
fluid resuscitation40-43, and the ideal resuscitation fluid for restoring microcirculatory flow 
dynamics should act to restore the endothelial glycocalyx44. Whether additional 
microcirculatory data might direct fluid resuscitation towards a plasma-based strategy in the 
clinical situation is yet to be determined. Further clinical investigation of this is warranted.  
 
Limitations 
This study included a relatively small number of patients, with all of the associated statistical 
limits. Analysis was performed on an individual time-point (rather than individual patient) 
level in order to increase the number of data points to address our research question. The 
patients included in the current study were profoundly unwell, with high injury severity 
scores and poor physiological parameters on admission. The data from the current study may 
not necessarily be translatable for patients with less severe injuries and physiological burden. 
Sublingual video-microscopy is not currently in widespread clinical use, and the utility of 
these data in the clinical context are yet to be examined in prospective clinical trials. 
 
We present for the first time an association between endotheliopathy (including endothelial 
cell damage and glycocalyx shedding) and alterations in flow, density, functional density, 
proportion of perfused vessels, and micro-vessel heterogeneity. This microcirculatory 
dysfunction may explain in part some of the mechanisms of the oxygen perfusion deficit that 
is attributable to endotheliopathy. The clinical utility of these flow parameters at the bedside 
is yet to be elucidated.    
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Figure legends 
 
Figure 1. The relationship between (a) thrombomodulin and (b) syndecan-1 concentrations 
and lactate for all patients.  
 
Figure 2. Concentrations of (a) syndecan-1 and (b) thrombomodulin over the study time-
points for all patients compared to healthy controls (HCs).  
*p < 0.05; **p < 0.01 vs HCs using Dunn’s multiple comparison’s test  
 
Figure 3. Flow dynamics for all patients over time, including (a) Microcirculatory Flow Index; 
(b) Proportion of Perfused Vessels; (c) Microcirculatory Heterogeneity Index; and (d) Point of 
Care Microcirculation score.   
**p < 0.01; ***p < 0.001 using the Skillings-Mack test 
 
Figure 4. Concentrations of syndecan-1 at each time-point, dichotomised to “above” and 
“below” the average values of (a) Microcirculatory Heterogeneity Index; (b) Proportion of 
Perfused Vessels; and (c) Point of Care Microcirculation score; and (d) Microcirculatory 
Flow Index compared to healthy controls (HCs). 
*p < 0.05, **p < 0.01; ***p < 0.001 vs HCs using Dunn’s multiple comparison’s test  
 
Figure 5. Concentrations of thrombomodulin at each time-point, dichotomised to “above” 
and “below” the average values of (a) Total Vessel Density; (b) Perfused Vessel Density; (c) 
Proportion of Perfused Vessels; and (d) Microcirculatory Flow Index compared to healthy 
controls (HCs). 
*p < 0.05 vs HCs using Dunn’s multiple comparison’s test  
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Supplementary Digital Content Figure 1. The relationship between thrombomodulin and 
syndecan-1 concentrations for all patients and healthy controls.  
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 Table 1. Study patient characteristics 
Patient characteristic All 
Age, years 35 (25–52) 
Sex, male:female 16:1 
Mechanism of injury  
         Road traffic accident 10 
         Stabbing 4 
         Fall 2 
         Crush 1 
Injury Severity Score 27 (23–34) 
Physiological parameters on arrival   
         Heart rate, min-1 108 (98–118)  
         Systolic blood pressure, mmHg 91 (61–108) 
         Glasgow Coma Scale 9 (3–14)  
         Serum lactate, mmol/l 6.0 (3.6–10.2)  
Blood products required in ED  
         Packed red cells, units 3 (2–4)  
         Fresh frozen plasma, units 2 (0–4)  
Outcomes  
         ICU-free days 11 (0–19) 
         Hospital-free days 0 (0–5)  
         SOFA score, day 3 6 (8 – 9)  
         SOFA score, day 6 4 (3 – 6)  
         SOFA score, day 10 3 (3 – 4)  
         30 day mortality 3 
Summary data are presented as median and interquartile range in parentheses; categorical data are 
reported as N. ICU- and Hospital-free days are calculated for a 30-day period.  
ED: Emergency Department; ICU: Intensive Care Unit; SOFA: Sequential Organ Failure Assessment 
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